{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Obstetrical and Gynecological Survey - Vol. 76, No. 9
Activity Steps
{{ evaluation.question.text }}
{{choice.text}}
{{evaluation.answerSet[0].text}}
Description
Method of Participation in the Learning Process/Evaluation Method Successful completion of this activity includes reading the entire article and successfully completing the post-quiz and an evaluation form. Getting the Most out of the Activity As you prepare to participate in this activity, please reflect on your practice and your patients and identify clinical challenges you hope to have addressed. While participating in the training, identify ways you can use newly acquired knowledge, strategies, and skills to enhance patient outcomes and your own professional development.Learning Objectives
After completing this continuing education activity you will be able to:
- CME Article 25: Management of Complicated Monochorionic Twin Gestations: An Evidence-Based Protoco -- Describe the sonographic findings used to establish the diagnosis of MC twin pregnancies; identify complications unique to MC twins pregnancies, including twin-twin transfusion syndrome, twin reversed arterial perfusion sequence, twin anemia polycythemia syndrome, co-twin demise, cord entanglement, and conjoined twins; and explain the management of complications associated with MC twin pregnancies.
- CME Article 26: Spontaneous Renal Rupture During Pregnancy: A Contemporary Literature Review and Guide to Management -- identify the risk factors of spontaneous renal rupture in pregnancy; outline the presenting signs and symptoms of renal system rupture during pregnancy; explain the preferred diagnostic tools and imaging modalities for diagnosing renal system rupture in pregnancy, including the risks and benefits to the fetus; and describe the management and potential complications of pregnant patients presenting with renal system rupture.
- CME Article 27: Hereditary Angioedema in Pregnancy-- identify the potential morbidity and mortality associated with hereditary angioedema; describe how hereditary angioedema can affect the care plan and outcome of pregnancy in affected patients, including labor and delivery; and explain what treatments are used in the management of hereditary angioedema during pregnancy.
Disclosures
Regarding CME Article 27 : K.E.B. acted as consultant to CSL/Takeda; and S.D.B. received advisory fee from CSL/Takeda. The remaining author, faculty, and staff in a position to control the content of this CME activity have disclosed that they have no financial relationships with, or financial interests in, any commercial organizations relevant to this educational activity.
Lippincott CME Institute has identified and resolved all conflicts of interest concerning this educational activity. Regarding CME Article 26: Disclaimer: J.A.P. is an active duty member of the Armed Forces. The views expressed are those of the author(s) and do not reflect the official policy of the Department of the Army, Department of Defense, or the US Government. The investigators have adhered to the policies for protection of human subjects as prescribed in 45 CFR 46. Off-Label UsageDr. Binkley has disclosed that the U.S. Food and Drug Administration has not approved the use of any drugs or devices for the treatment of hereditary angioedema as discussed in this article. Please consult the product's labeling for approved information.
Price:
$30.00
Credits:
- ACCME 3.0 CME
Lippincott Continuing Medical Education Institute, Inc. is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.Lippincott Continuing Medical Education Institute, Inc. designates this enduring material for a maximum of 3.0 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
{{ evaluation.question.text }}
{{choice.text}}
{{evaluation.answerSet[0].text}}
Professions:
Physician
Test Code: OGS0921
Published: September 2021
Expires: 8/31/2023
Sources:
Obstetrical & Gynecological Survey
Required Passing Score: 9/12 (75%)
Categories:
Gynecological
,
Obstetrical
Specialties:
Gynecology,
OB/GYN